|
|
|
|
Despite the lack of evidence of its efficacy,heparin therapy has been recommended for selected patients with ischemic stroke syndromes.However, heparin has procoagulant effects on platelet function and a propensity to produce serious side effects.When these factors are considered,heparin loses its appeal as a therapeutic agent for patients with acute focal cerebral ischemia. |
|